Skip to main content
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1975 May;72(5):1684–1686. doi: 10.1073/pnas.72.5.1684

Biological properties of plasmin digests of S-carbamidomethylated human growth hormone.

C R Reagan, J B Mills, J L Kostyo, A E Wilhelmi
PMCID: PMC432608  PMID: 125419

Abstract

Reduction and carbamidomethylation of the intrachain disulfide bridges of human growth hormone did not destroy its ability to stimulate weight gain or cartilage metabolism in hypophysectomized rats. The reduced and alkylated hormone also stimulated glucose oxidation in isolated adipose tissue of hypophysectomized rats when added in vitro. When the S-carbamidomethylated hormone was incubated overnight with human plasmin, approximately 95% of the starting material was completely digested, as judged by polyacrylamide gel electrophoresis. The plasmin digest retained the ability to stimulate weight gain, cartilage metabolism, and glucose oxidation. A fraction consisting of two major electrophoretic components was isolated from the digest by chromatography on tsephadex G-50. This fraction possessed the biological properties of the whole digest.

Full text

PDF
1684

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Cerosi E., Li C. H., Luft R. Some metabolic changes induced by acute administration of native and reduced-tetra-S-carbamidomethylated human growth hormone in man. J Clin Endocrinol Metab. 1972 Apr;34(4):644–649. doi: 10.1210/jcem-34-4-644. [DOI] [PubMed] [Google Scholar]
  2. Connors M. H., Kaplan S. L., Li C. H., Grumbach M. M. Retention of biologic activity of human growth hormone in man after reduction and alkylation. J Clin Endocrinol Metab. 1973 Oct;37(4):499–504. doi: 10.1210/jcem-37-4-499. [DOI] [PubMed] [Google Scholar]
  3. Dixon J. S., Li C. H. Retention of the biological potency of human pituitary growth hormone after reduction and carbamidomethylation. Science. 1966 Nov 11;154(3750):785–786. doi: 10.1126/science.154.3750.785. [DOI] [PubMed] [Google Scholar]
  4. Li C. H., Gráf L. Human pituitary growth hormone: isolation and properties of two biologically active fragments from plasmin digests. Proc Natl Acad Sci U S A. 1974 Apr;71(4):1197–1201. doi: 10.1073/pnas.71.4.1197. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Mills J. B., Reagan C. R., Rudman D., Kostyo J. L., Zachariah P., Wilhelmi A. E. Metabolic effects of plasmin digests of human growth hormone in the rat and man. J Clin Invest. 1973 Nov;52(11):2941–2951. doi: 10.1172/JCI107491. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. ORNSTEIN L. DISC ELECTROPHORESIS. I. BACKGROUND AND THEORY. Ann N Y Acad Sci. 1964 Dec 28;121:321–349. doi: 10.1111/j.1749-6632.1964.tb14207.x. [DOI] [PubMed] [Google Scholar]
  7. Parlow A. F., Wilhelmi A. E., Reichert L. E., Jr Further studies on the fractionation of human pituitary glands. Endocrinology. 1965 Dec;77(6):1126–1134. doi: 10.1210/endo-77-6-1126. [DOI] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES